Urushibara, Soki
Hara, Akemi
Nakamoto, Hirose
Ozawa, Haruhisa
Nemoto, Yuki
Watanabe, Shun
Ohata, Ryo
Sakai, Takuto
Sawano, Toyoaki
Ozaki, Akihiko
Kurokawa, Tomohiro
Okazaki, Masayuki
Kouchi, Yukiko
Tamada, Yutaka
Yoshida, Naoto
Tanimoto, Tetsuya
Yamabe, Fumito
Iizuka, Junpei
Takagi, Toshio
Hattori, Motoshi
Kawaguchi, Hiroshi
Shimmura, Hiroaki
Article History
Received: 5 May 2025
Accepted: 25 May 2025
First Online: 20 June 2025
Declarations
:
: This study was approved by the Ethics Committee of Jyoban Hospital of Tokiwa Foundation (approval no. JHTF-2024-029) and conducted in accordance with the ethical standards outlined in the Declaration of Helsinki. An opt-out option was provided to participants for inclusion in the study. All patient data were anonymized to ensure privacy protection.
: Not applicable, as no individual patient-identifiable data are presented.
: Dr. Akihiko Ozaki received personal fees from Medical Network Systems Inc., Kyowa Kirin Inc., Becton, Dickinson and Company, Pfizer, Daiichi Sankyo Inc., and Taiho Pharmaceutical Co., Ltd., outside the submitted work. Dr. Tetsuya Tanimoto reported receiving personal fees from Bionics Co., Ltd. and Medical Network Systems Inc. outside of the submitted work. Other authors declare that they have no competing interests.